CoChat

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index; none of the 73 sources its claims cite is checked for support yet.

Evidence for a clathrin-independent endocytic pathway for APP internalization in the neuronal somatodendritic compartment

Open access

Abstract

Amyloid precursor protein (APP) internalization via clathrin-/dynamin-mediated endocytosis (CME) mediated by its YENPTY motif into endosomes containing β-secretase is proposed to be critical for amyloid-beta (Aβ) production. Here, we show that somatodendritic APP internalization in primary rodent neurons is not blocked by inhibiting dynamin or mutating the YENPTY motif, in contrast to non-neuronal cell lines. These phenomena, confirmed in induced human neurons under dynamin inhibition, occur during basal conditions and chemical long-term-depression stimulus, pointing to a clathrin-independent internalization pathway for somatodendritic APP. Mutating the YENPTY motif does not alter APP recycling, degradation, or endolysosomal colocalization. However, both dynamin inhibition and the YENPTY mutant significantly decrease secreted Aβ in neurons, suggesting that internalized somatodendritic APP may not constitute a major source of Aβ. Interestingly, like APP, somatodendritic low-density lipoprotein receptor (LDLR) internalization does not require its CME motif. These results highlight intriguing differences in neuronal internalization pathways and refine our understanding of Aβ production and secretion.

Overview

CoChat Summary

TL;DR

In primary rodent and human neurons, somatodendritic APP internalization is not blocked by dynamin inhibition or mutation of the YENPTY motif, unlike in non-neuronal cell lines, indicating a clathrin-independent pathway. Despite this, dynamin inhibition or the YENPTY mutant markedly reduces secreted Aβ, suggesting internalized somatodendritic APP is not a major source of Aβ.

Key findings

  • In primary hippocampal neurons, NMDA application induced a significant ~25% decrease in the somatodendritic Sep/mCherry fluorescence ratio, which was blocked by AP-5 but not by dynasore or the Sep-APP-YENPTY mutant (AENATY).
  • Using the BTX internalization assay, Dyngo-4a decreased APP internalization by ~85% in HeLa and N2a cells and by ~70%–90% in CHO, HEK293, and B103 cells, but increased somatodendritic APP internalization by >50% in primary neurons. APP-4A internalization was not different from APP-WT in neurons, whereas it was reduced by ~85% in HeLa, ~30% in N2a, and ~75%–90% in CHO/HEK293/B103 cells.
  • LDLR-4A internalization was reduced by ~70% in HeLa cells but showed no change in primary neurons. In PLA experiments, ~70% of PLA puncta had no overlap (<10% overlapping voxels) with BTX puncta, and only ~12% showed >50% overlap. C99 levels were ~75% lower in APP-4A neurons, and secreted Aβ40/Aβ42 were similarly reduced; Dyngo-4a reduced Aβ40 and Aβ42 by ~60%.
  • Antibody-feeding assays with 22C11 or polyclonal GFP antibody showed Dyngo-4a decreased APP internalization by ~70% and ~90%, respectively, whereas the monovalent GFP nanobody GBA647 increased internalization with Dyngo-4a, consistent with BTX results.

Methods

  • Primary mouse hippocampal and cortical neurons, H9ESC-derived human neurons, and non-neuronal cell lines (HeLa, N2a, CHO, HEK293FT, B103) were used. Assays included live imaging of Sep-APP/mCherry, BTX-based internalization, surface biotinylation, lentiviral APP-WT/APP-4A expression, proximity ligation assay (PLA), Western blotting, and Aβ40/Aβ42 ELISA.
  • Internalization was quantified as intracellular A647-BTX fluorescence divided by surface-labeled Sep fluorescence, or by biotinylated APP pulldown; colocalization and PLA overlap were analyzed with ImageJ, MATLAB, Imaris, and R. Statistical comparisons used t tests with Welch’s correction or one-way ANOVAs, with results presented as mean ± SEM.

Limitations

  • The paper states that BTX labeling cannot mark APP molecules not trafficked to the cell surface, such as newly synthesized APP, leaving their intracellular routes opaque; fluorescent microscopy also cannot resolve single APP-BTX molecule movements, and the study did not examine APP internalization into TGN or multivesicular bodies.
  • Evident from the text: several key assays rely on transfected or lentivirally expressed APP constructs, although endogenous APP biotinylation and human neuron experiments were also performed; the specific dynamin-independent pathway was not identified; and antibody-feeding results indicate that bivalent antibodies can induce APP clustering and alter the internalization pathway.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2023.112774

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. NMDA application induces Sep-APP internalization in a dynamin-independent and YENPTY-motif-independent manner (A) Representative maximal z-projections of primary hippocampal neurons transfected with Sep-APP and cytoplasmic mCherry (rows i–v and vii) or Sep-APP-YENPTY mutant and cytoplasmic mCherry (row vi), and imaged live before (left three panels) and after (right three panels) application of various drugs (i: control; ii: NMDA; iii: NMDA+AP-5; iv: NMDA+Tapi-2; v: NMDA+dynasore; vi: NMDA+APP-YENPTY mutant; vii: dynasore alone). Sep (green) and mCherry (red) fluorescence are shown separately for clarity; merge indicates merged images. Scale bar, 10 μm. (B) Quantification of Sep/mCherry ratios (normalized to the 1st image) across the experimental conditions shown in (A). Values from individual neurons are shown as open circles (i: N = 15; ii: N = 16; iii: N = 10; iv: N = 9; v: N = 11; vi: N = 9; vii: N = 11). Error bars denote SEM. Exact p values are shown comparing the control condition and each of the other five conditions following post hoc multiple comparisons (one-way Brown-Forsythe ANOVA F(6.00, 20.74) = 5.108, p = 0.0023).
Figure 1. NMDA application induces Sep-APP internalization in a dynamin-independent and YENPTY-motif-independent manner (A) Representative maximal z-projections of primary hippocampal neurons transfected with Sep-APP and cytoplasmic mCherry (rows i–v and vii) or Sep-APP-YENPTY mutant and cytoplasmic mCherry (row vi), and imaged live before (left three panels) and after (right three panels) application of various drugs (i: control; ii: NMDA; iii: NMDA+AP-5; iv: NMDA+Tapi-2; v: NMDA+dynasore; vi: NMDA+APP-YENPTY mutant; vii: dynasore alone). Sep (green) and mCherry (red) fluorescence are shown separately for clarity; merge indicates merged images. Scale bar, 10 μm. (B) Quantification of Sep/mCherry ratios (normalized to the 1st image) across the experimental conditions shown in (A). Values from individual neurons are shown as open circles (i: N = 15; ii: N = 16; iii: N = 10; iv: N = 9; v: N = 11; vi: N = 9; vii: N = 11). Error bars denote SEM. Exact p values are shown comparing the control condition and each of the other five conditions following post hoc multiple comparisons (one-way Brown-Forsythe ANOVA F(6.00, 20.74) = 5.108, p = 0.0023).CC BY-NC-ND · PubMed Central
Figure 2. Inhibiting dynamin or mutating the YENPTY motif significantly decreases APP internalization in cell lines but not in the somatodendritic compartment of primary neurons (A–C) Representative images of APP/BTX internalization in HeLa cells (A), N2a cells (B), and primary neurons (C) in the presence of DMSO (top panels in A–C) or Dyngo-4a (bottom panels in A–C). Internalized APP is bound to fluorescent BTX (internalized BTX, red); surface APP levels detected by immunostaining against Sep are shown in green (as in E–G). The ratio of internalized BTX to surface APP levels is quantified as the amount of APP internalization (as in E–G). Virtually no BTX is present upon Dyngo-4a application in HeLa cells and N2a cells (A and B); in contrast, more BTX is observed in the somatodendritic compartment of primary neurons (C). Arrows in (C) indicate analyzed dendrites, and the arrowheads indicate excluded axons. Scale bar, 10 μm. (D) Quantification of results in (A)–(C). Individual values are shown as open circles. For (A), N > 70 cells for both conditions, n = 4 experiments; p < 0.0001, t test with Welch’s correction (as in B, C, and E–G). For (B), N > 100 cells for both conditions, n = 5 experiments; p < 0.0001. For (C), N > 50 neurons for both conditions, n = 9 experiments; for soma, p < 0.0001; for dendrites, p = 0.0012. Error bars denote SEM (as in H). (E–G) Representative images of APP/BTX internalization in HeLa cells (E), N2a cells (F), and primary neurons (G) in the APP-WT (top panels, “-WT”) or APP-4A mutant (bottom panels, “−4A”). Arrows in (G) indicate analyzed dendrites, and arrowheads indicate excluded axons. Scale bar, 10 μm. (H) Quantification of results in (E)–(G). Individual values are shown as open circles. For (E), N > 150 cells for both conditions, n = 4 experiments; p < 0.0001. For (F), N > 150 cells for both conditions, n = 5 experiments; p < 0.0001. For (G), N > 50 neurons for both conditions, n = 10 experiments; for soma, p > 0.05; for dendrites, p > 0.05.
Figure 2. Inhibiting dynamin or mutating the YENPTY motif significantly decreases APP internalization in cell lines but not in the somatodendritic compartment of primary neurons (A–C) Representative images of APP/BTX internalization in HeLa cells (A), N2a cells (B), and primary neurons (C) in the presence of DMSO (top panels in A–C) or Dyngo-4a (bottom panels in A–C). Internalized APP is bound to fluorescent BTX (internalized BTX, red); surface APP levels detected by immunostaining against Sep are shown in green (as in E–G). The ratio of internalized BTX to surface APP levels is quantified as the amount of APP internalization (as in E–G). Virtually no BTX is present upon Dyngo-4a application in HeLa cells and N2a cells (A and B); in contrast, more BTX is observed in the somatodendritic compartment of primary neurons (C). Arrows in (C) indicate analyzed dendrites, and the arrowheads indicate excluded axons. Scale bar, 10 μm. (D) Quantification of results in (A)–(C). Individual values are shown as open circles. For (A), N > 70 cells for both conditions, n = 4 experiments; p < 0.0001, t test with Welch’s correction (as in B, C, and E–G). For (B), N > 100 cells for both conditions, n = 5 experiments; p < 0.0001. For (C), N > 50 neurons for both conditions, n = 9 experiments; for soma, p < 0.0001; for dendrites, p = 0.0012. Error bars denote SEM (as in H). (E–G) Representative images of APP/BTX internalization in HeLa cells (E), N2a cells (F), and primary neurons (G) in the APP-WT (top panels, “-WT”) or APP-4A mutant (bottom panels, “−4A”). Arrows in (G) indicate analyzed dendrites, and arrowheads indicate excluded axons. Scale bar, 10 μm. (H) Quantification of results in (E)–(G). Individual values are shown as open circles. For (E), N > 150 cells for both conditions, n = 4 experiments; p < 0.0001. For (F), N > 150 cells for both conditions, n = 5 experiments; p < 0.0001. For (G), N > 50 neurons for both conditions, n = 10 experiments; for soma, p > 0.05; for dendrites, p > 0.05.CC BY-NC-ND · PubMed Central
Figure 3. Mutating the YENPTY motif decreases LDLR internalization in HeLa cells but not in the somatodendritic compartment of primary neurons (A) Representative images of LDLR/BTX internalization in HeLa cells in the LDLR-WT (top panels, “-WT”) or LDLR-NPVY mutant (bottom panels, “-AAAA”). Internalized LDLR is bound to fluorescent BTX (internalized BTX, red); surface LDLR levels detected by immunostaining against GFP are shown in green (as in D). The ratio of internalized BTX to surface LDLR levels is quantified as the amount of LDLR internalization (as in D). Scale bar, 10 μm. (B) Quantification of results in (A). Individual values are shown as open circles. N > 100 cells for both conditions, n = 4 experiments; p < 0.0001, t test with Welch’s correction (as in D). Error bars denote SEM (as in D). (C) As in (A), representative images of LDLR/BTX internalization in primary neurons in the LDLR-WT (top panels, “-WT”) or LDLR-NPVY mutant (bottom panels, “-AAAA”). Scale bar, 10 μm. (D) Quantification of results in (C). Individual values are shown as open circles. N > 20 neurons for both conditions, n = 3 experiments; for soma, p > 0.05; for dendrites, p > 0.05.
Figure 3. Mutating the YENPTY motif decreases LDLR internalization in HeLa cells but not in the somatodendritic compartment of primary neurons (A) Representative images of LDLR/BTX internalization in HeLa cells in the LDLR-WT (top panels, “-WT”) or LDLR-NPVY mutant (bottom panels, “-AAAA”). Internalized LDLR is bound to fluorescent BTX (internalized BTX, red); surface LDLR levels detected by immunostaining against GFP are shown in green (as in D). The ratio of internalized BTX to surface LDLR levels is quantified as the amount of LDLR internalization (as in D). Scale bar, 10 μm. (B) Quantification of results in (A). Individual values are shown as open circles. N > 100 cells for both conditions, n = 4 experiments; p < 0.0001, t test with Welch’s correction (as in D). Error bars denote SEM (as in D). (C) As in (A), representative images of LDLR/BTX internalization in primary neurons in the LDLR-WT (top panels, “-WT”) or LDLR-NPVY mutant (bottom panels, “-AAAA”). Scale bar, 10 μm. (D) Quantification of results in (C). Individual values are shown as open circles. N > 20 neurons for both conditions, n = 3 experiments; for soma, p > 0.05; for dendrites, p > 0.05.CC BY-NC-ND · PubMed Central
Figure 4. APP internalization in HeLa cells, murine primary neurons, and human differentiated neurons assessed by surface biotinylation is consistent with imaging results (A) Left: representative western blot of internalized APP (detected by Y188 antibody) in HeLa cells in the presence of DMSO (left two lanes) or Dyngo-4a (right two lanes). Internalized APP is calculated by taking the intensity of the lane after glutathione treatment (“glutathione strip: +”) divided by the lane without glutathione treatment (“glutathione strip: –”). Right panel: quantification of internalized/surface APP ratios in Dyngo-4a normalized to DMSO. Individual values are shown as open circles. n = 3 experiments; p = 0.033, paired t test with Welch’s correction (as in B–D). Error bars denote SEM (as in B–D). (B) As in (A) but with murine primary neurons and endogenous murine APP. Right panel; quantification of internalized/surface APP ratios in Dyngo-4a normalized to DMSO. Individual values are shown as open circles. n = 9 experiments; p > 0.05. (C) As in (B) but with murine primary neurons transduced with APP-WT lentivirus (“APP-WT,” left two lanes) or APP-4A mutant lentivirus (“APP-AEAATA,” right two lanes). Right panel; quantification of internalized/surface APP ratios in APP-4A normalized to APP-WT. Individual values are shown as open circles. n = 8 experiments; p > 0.05. (D) As in (B) but with hESC-differentiated neurons and endogenous human APP. Right panel: quantification of internalized/surface APP ratios in Dyngo-4a normalized to DMSO. Individual values are shown as open circles. n = 3 experiments; p > 0.05.
Figure 4. APP internalization in HeLa cells, murine primary neurons, and human differentiated neurons assessed by surface biotinylation is consistent with imaging results (A) Left: representative western blot of internalized APP (detected by Y188 antibody) in HeLa cells in the presence of DMSO (left two lanes) or Dyngo-4a (right two lanes). Internalized APP is calculated by taking the intensity of the lane after glutathione treatment (“glutathione strip: +”) divided by the lane without glutathione treatment (“glutathione strip: –”). Right panel: quantification of internalized/surface APP ratios in Dyngo-4a normalized to DMSO. Individual values are shown as open circles. n = 3 experiments; p = 0.033, paired t test with Welch’s correction (as in B–D). Error bars denote SEM (as in B–D). (B) As in (A) but with murine primary neurons and endogenous murine APP. Right panel; quantification of internalized/surface APP ratios in Dyngo-4a normalized to DMSO. Individual values are shown as open circles. n = 9 experiments; p > 0.05. (C) As in (B) but with murine primary neurons transduced with APP-WT lentivirus (“APP-WT,” left two lanes) or APP-4A mutant lentivirus (“APP-AEAATA,” right two lanes). Right panel; quantification of internalized/surface APP ratios in APP-4A normalized to APP-WT. Individual values are shown as open circles. n = 8 experiments; p > 0.05. (D) As in (B) but with hESC-differentiated neurons and endogenous human APP. Right panel: quantification of internalized/surface APP ratios in Dyngo-4a normalized to DMSO. Individual values are shown as open circles. n = 3 experiments; p > 0.05.CC BY-NC-ND · PubMed Central
Figure 5. The YENPTY motif does not affect the colocalization of internalized APP/BTX puncta with endolysosomal markers in the soma and dendrites (A) Representative images of internalized APP/BTX puncta (red) and the colabeled organelle marker (top row: Rab5, second row: Rab7, third row: Rab11, bottom row: Lamp1; all shown in green) in somas from neurons transfected with Sep-BBS-APP-WT or Sep-BBS-APP-4A. The somatic outline is shown in white; open regions indicate the beginning of dendritic branches. Colocalization examples between BTX puncta and the organelle marker are indicated by white arrows. Scale bar, 5 μm. (B) As in (A) but from the dendrites of neurons transfected with Sep-BBS-APP-WT or Sep-BBS-APP-4A. The dendritic outline is shown in white. Colocalization examples between BTX puncta and the organelle marker are indicated by white arrows. Scale bar, 5 μm. (C) Quantification of results in (A), showing the percentage of thresholded voxel overlap between APP/BTX and the respective organelle markers in the neuronal soma. Number of neurons for each condition (n = 3–4 experiments): Rab5: N = 15 (APP-WT), N = 12 (APP-4A); Rab7: N = 17 (APP-WT), N = 14 (APP-4A); Rab11: N = 12 (APP-WT), N = 14 (APP-4A); Lamp1: N = 14 (APP-WT), N = 14 (APP-4A). NS, not significant (p > 0.05); t test with Welch’s correction (as in D). Error bars denote SEM (as in D). (D) Quantification of results in (B). The number of neurons analyzed is the same as in (A).
Figure 5. The YENPTY motif does not affect the colocalization of internalized APP/BTX puncta with endolysosomal markers in the soma and dendrites (A) Representative images of internalized APP/BTX puncta (red) and the colabeled organelle marker (top row: Rab5, second row: Rab7, third row: Rab11, bottom row: Lamp1; all shown in green) in somas from neurons transfected with Sep-BBS-APP-WT or Sep-BBS-APP-4A. The somatic outline is shown in white; open regions indicate the beginning of dendritic branches. Colocalization examples between BTX puncta and the organelle marker are indicated by white arrows. Scale bar, 5 μm. (B) As in (A) but from the dendrites of neurons transfected with Sep-BBS-APP-WT or Sep-BBS-APP-4A. The dendritic outline is shown in white. Colocalization examples between BTX puncta and the organelle marker are indicated by white arrows. Scale bar, 5 μm. (C) Quantification of results in (A), showing the percentage of thresholded voxel overlap between APP/BTX and the respective organelle markers in the neuronal soma. Number of neurons for each condition (n = 3–4 experiments): Rab5: N = 15 (APP-WT), N = 12 (APP-4A); Rab7: N = 17 (APP-WT), N = 14 (APP-4A); Rab11: N = 12 (APP-WT), N = 14 (APP-4A); Lamp1: N = 14 (APP-WT), N = 14 (APP-4A). NS, not significant (p > 0.05); t test with Welch’s correction (as in D). Error bars denote SEM (as in D). (D) Quantification of results in (B). The number of neurons analyzed is the same as in (A).CC BY-NC-ND · PubMed Central
Figure 6. PLA puncta do not overlap significantly with internalized APP/BTX puncta (A) Representative images showing the overlap between somatodendritic internalized APP/BTX puncta (red), PLA puncta (green), and merged. The neuronal outline is shown in white. Inset (blue box) shows a magnified area from the soma in which the majority of APP/BTX puncta and PLA puncta do not overlap. Arrows denote rare instances of overlap between APP/BTX puncta and PLA puncta. Scale bar, 10 μm. (B) Histogram plot of results in (A). Within a single neuron, the percentage voxel overlap for each PLA puncta with any neighboring BTX signal is measured, with values ranging from 0% (no overlap) to 100% (complete overlap). The x axis displays the percentage overlap bins in 10% increments; overlaps >50% are binned together. Histogram columns indicate the proportion of PLA puncta in each neuron that have a BTX overlap percentage in that column; N = 918 PLA puncta from n = 19 neurons, individual values for each neuron shown as open circles. As an example, averaging across the 19 neurons, ~70% of PLA puncta have 0%–9% overlap with the BTX signal, ~5% of PLA puncta have a 20%–29% overlap with the BTX signal, and ~12.5% of PLA puncta have a >50% overlap with the BTX signal.
Figure 6. PLA puncta do not overlap significantly with internalized APP/BTX puncta (A) Representative images showing the overlap between somatodendritic internalized APP/BTX puncta (red), PLA puncta (green), and merged. The neuronal outline is shown in white. Inset (blue box) shows a magnified area from the soma in which the majority of APP/BTX puncta and PLA puncta do not overlap. Arrows denote rare instances of overlap between APP/BTX puncta and PLA puncta. Scale bar, 10 μm. (B) Histogram plot of results in (A). Within a single neuron, the percentage voxel overlap for each PLA puncta with any neighboring BTX signal is measured, with values ranging from 0% (no overlap) to 100% (complete overlap). The x axis displays the percentage overlap bins in 10% increments; overlaps >50% are binned together. Histogram columns indicate the proportion of PLA puncta in each neuron that have a BTX overlap percentage in that column; N = 918 PLA puncta from n = 19 neurons, individual values for each neuron shown as open circles. As an example, averaging across the 19 neurons, ~70% of PLA puncta have 0%–9% overlap with the BTX signal, ~5% of PLA puncta have a 20%–29% overlap with the BTX signal, and ~12.5% of PLA puncta have a >50% overlap with the BTX signal.CC BY-NC-ND · PubMed Central
Figure 7. Reduced Aβ secretion in the APP-YENPTY mutant and in the presence of Dyngo-4a (A) Left: representative western blot of full-length APP (fl-APP; top bands) and β-CTF/C99 (bottom bands) immunoblotted from lysates of neuronal cultures transduced with lentiviruses expressing APP-WT or the APP-YENPTY mutant (APP-4A). Right panel: quantification of the β-CTF/fl-APP ratio for both APP-WT and APP-4A. Individual values are shown as open circles. n = 4 experiments; p = 0.0048, paired t test with Welch’s correction (as in B and C). Error bars denote SEM (as in B and C). (B) Levels of Aβ40 (left panel) and Aβ42 (right panel) present in media from neuronal cultures transduced with lentiviruses expressing APP-WT or the APP-4A mutant. Individual values are shown as open circles. n = 4 experiments; Aβ40: p < 0.0001; Aβ42: p < 0.0001. (C) As in (B) but measuring the levels of Aβ40 (left panel) and Aβ42 (right panel) produced and secreted from primary neurons lentivirally transduced with APP-WT in the presence of DMSO or Dyngo-4a over a 4 h period. Individual values are shown as open circles. n = 6 experiments; Aβ40: p = 0.0003; Aβ42: p = 0.0009.
Figure 7. Reduced Aβ secretion in the APP-YENPTY mutant and in the presence of Dyngo-4a (A) Left: representative western blot of full-length APP (fl-APP; top bands) and β-CTF/C99 (bottom bands) immunoblotted from lysates of neuronal cultures transduced with lentiviruses expressing APP-WT or the APP-YENPTY mutant (APP-4A). Right panel: quantification of the β-CTF/fl-APP ratio for both APP-WT and APP-4A. Individual values are shown as open circles. n = 4 experiments; p = 0.0048, paired t test with Welch’s correction (as in B and C). Error bars denote SEM (as in B and C). (B) Levels of Aβ40 (left panel) and Aβ42 (right panel) present in media from neuronal cultures transduced with lentiviruses expressing APP-WT or the APP-4A mutant. Individual values are shown as open circles. n = 4 experiments; Aβ40: p < 0.0001; Aβ42: p < 0.0001. (C) As in (B) but measuring the levels of Aβ40 (left panel) and Aβ42 (right panel) produced and secreted from primary neurons lentivirally transduced with APP-WT in the presence of DMSO or Dyngo-4a over a 4 h period. Individual values are shown as open circles. n = 6 experiments; Aβ40: p = 0.0003; Aβ42: p = 0.0009.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 38 Not checked · 105 Own results and interpretations

48 more claims

Create a free account to see all 143 claims and to verify the 72 references still open.

See all claims — free account
  • The quote only partly states this claim. 1
  • It may state two separate claims as one. 44
  • Probably not a substantial claim. 59

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 16

Metadata

Authors
Aow, J., Huang, T.-R., Goh, Y. T., Sun, A. X., Thinakaran, G., & Koo, E. H.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • National University of Singapore (SG)
  • University of South Florida (US)
Corresponding author
  • Aow, Jonathan
  • Koo, Edward H.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2023-07
Volume
42
Issue
7
Pages
112774
ISSN
2211-1247 (ISSN-L)
OpenAlex
W4384023964
Cited by
16
References
70
Citations by year
2026: 10 · 2025: 1 · 2024: 3 · 2023: 2
FWCI
1.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Reports (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Life Sciences Institute
  • National Medical Research Council (NMRC/StaR/009/2012)
  • National University of Singapore
  • Genome Institute of Singapore
  • National Institutes of Health (MOH-000237-00, NS84324)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
amyloid precursor protein, clathrin-independent endocytosis, dynamin, amyloid-beta production, neurons, LDL receptor, endosomes, beta-secretase
MeSH terms
Alzheimer Disease, Clathrin, Endocytosis, Humans, Neurons, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Dynamins, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.